- Neurophos raises $110 million - LEADOPTIK FDA cleared; first human trials - Cambridge Terahertz strategic funding - Kapta Space series A launch - MetaVC Partners talks photonics in Europe - Lumotive and Cephia at CES 2026 |
|
Video: Patrick Bowen (Neurophos) and Michael Stewart (Microsoft) |
|
NEUROPHOS (Austin, TX) closed a landmark $110 million Series A financing, led by Gates Frontier with strong participation from Microsoft’s venture fund M12 and other investors—bringing total funding to $118 million and validating the strategic potential of photonic AI compute architecture. Neurophos aims to deliver step-function improvements in performance and energy efficiency for large-scale AI inference by leveraging ultra-dense optical processing units built on metamaterials. Click on video above for Bloomberg TV interview. |
|
Photo: Sam Heidari, CEO of Lumotive |
|
LUMOTIVE (San Jose, CA) expanded in two new locations in Oman and Taiwan. On the heals of winning the 2025 “Startup to Watch” award at the Global Semiconductor Alliance (GSA) event in Silicon Valley in December, Lumotive exhibited at CES 2026 in Las Vegas and presented at the 28th annual Needham Growth Conference in New York. |
|
CAMBRIDGE TERAHERTZ (Santa Clara, CA): On the heels of closing the oversubscribed $12 million series Seed round in 2025, the company secured a strategic investment from the former CEO of TSMC (TSMC is the largest semiconductor manufacturer in the world). The company recently recruited the former chief security officer of Microsoft Corporation to their advisory board. |
|
RESOLV TECHNOLOGY (Boston, MA) closed an oversubscribed $5 million seed round led by MetaVC Partners and has established its first headquarters and lab and is nearing initial in-lab operation of its next-generation handheld scanner—a key milestone toward customer pilots. |
|
COMPUTATIONAL IMAGING AT CES |
|
Photos: (L) Cephia at CES 2026; (R) Palmer Luckey, founder of Anduril and Occulus VR |
|
CEPHIA (San Francisco, CA): The company finished their first packaged prototype camera and software in record time and exhibited to customers and partners at the 2026 Consumer Electronics Show (CES) in Las Vegas in January. The company is productizing a new range of software defined cameras to be used in multiple billion-dollar markets, ranging from food, drugs, and semiconductor manufacturing quality control. |
|
Video: MetaVC Partners talks opportunities CLICK ON VIDEO ABOVE |
|
SENSETICS (Princeton, NJ) achieved several major technical milestones this quarter, advancing its programmable metamaterial platform toward super-human touch sensing. Strategic discussions are underway with humanoid robotics, haptics, and electronics partners. |
|
FDA CLEAR AND HUMAN TRIALS |
|
LEADOPTIK (San Jose, CA): The big news to end 2025 is that the company received final U.S. FDA clearance for both the system console and software and the consumables (catheter). Read it here. First in-human trials were completed in January on several patients at one of the leading hospitals in the country specializing in lung cancer treatment. |
|
KAPTA SPACE (Seattle, WA) enters 2026 ready to pursue a Series A in February, targeting a multibillion-dollar opportunity in space-based radar imaging and tracking. The company’s metamaterials-enabled electronically scanned array architecture has continued to mature, validating a credible path to best-in-class performance at constellation-scale economics. |
|
Thank you for your support. MetaVC Partners San Francisco | Seattle |
|
1525 Miramonte Avenue, PO Box 3404 Los Altos, CA 94024, USA |
|
|
|